Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Grant or award Director acquired 39,330 shares (grant or award)
  2. 4 Grant or award Director acquired 23,814 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy 10% owner bought 122,804 shares at an average $1.96 ($240,522)
  9. 3/A Insider 3/A
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy 10% owner bought 3,236,290 shares at $1.44 ($4,660,258)
  12. 4 Option exercise 10% owner acquired 1,552,047 shares (option exercise)
  13. 3 Insider Initial Statement of Ownership
  14. 5 Insider Annual Insider Trading Report
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy 10% owner bought 972,222 shares at $1.44 ($1,400,000)
  19. 4 Open-market buy 10% owner bought 1,288,339 shares at $1.44 ($1,855,208)
  20. 4 Open-market buy Director bought 16,502 shares at $1.44 ($23,763)

Page 16 of 28 · 551 filings